XOMA

$23.36 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About XOMA

XOMA Corporation is a biopharmaceutical company that develops and manufactures genetically engineered protein, peptide, and antibody pharmaceuticals. The Company's medical targets include bacterial and fungal infections, infectious complications, and immunologic and inflammatory disorders. XOMA's primary drug development platform is bactericidal/permeability-increasing protein.

Stock Analysis

last close $25.79
1-mo return 6%
3-mo return -20.1%
avg daily vol. 27.23T
52-week high 46.32
52-week low 19.26
market cap. $292M
forward pe -
annual div. -
roe 10%
ltg forecast -
dividend yield -
annual rev. $29M
inst own. 59.8%
baraka

Subscribe now for daily local and international financial news

Subscribe